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The penetration of sparfloxacin into human neutrophils (PMN) and different tissue culture cells (HEp-2 and
McCoy) was evaluated. The cellular to extracellular concentration ratios (C/E) of sparfloxacin were always
higher than 4 at extracellular concentrations ranging from 0.5 to 25 mg/liter. The uptake of sparfiloxacin by
PMN was rapid, nonsaturable, reversible, not energy dependent, and significantly reduced at pH 8. The
penetration of this agent into PMN was similar when viable and Formalin-killed cells were used and was not
affected by environmental temperature. Ingestion of opsonized zymosan significantly increased the amount of
PMN-associated sparfloxacin. Sparfloxacin at a concentration of 0.5 mg induced a significant reduction in the
survival of intracellular Staphylococcus aureus. It is concluded that sparfloxacin reaches intracellular
concentrations within leukocytic cells much higher than extracellular concentrations, while remaining active
intracellularly.
Most of the new quinolones have shown high intracellular
penetration in different phagocytic and nonphagocytic cells.
Moreover, these antimicrobial agents have been shown to be
effective agents against typical facultative intracellular
pathogens such as Legionella spp. and against other bacte-
ria, such as Staphylococcus aureus, that in certain circum-
stances are able to survive and even multiply within phago-
cytic cells (2, 3, 11).
Nevertheless, most quinolones have limited activity
against gram-positive cocci. Sparfloxacin is a new quinolone
with two fluorinated substituents that has been associated
with greater activity against gram-positive cocci than other
quinolones (7). It was found to be more active against
clinical isolates of S. aureus, including quinolone-resistant
S. aureus, than the existing quinolones (8). Moreover,
sparfloxacin offers an increased half-life and good tissue
distribution (9).
The purpose of this study was to evaluate the uptake of
sparfloxacin by human polymorphonuclear leukocytes
(PMN) and tissue culture epithelial cells. The possible mech-
anism involved in the penetration of this quinolone into
phagocytic cells and its intracellular activity against S.
aureus was also evaluated.
MATERLILS AND METHODS
Isolation of PMN. PMN were recovered from heparinized
venous blood of healthy donors by dextran sedimentation
and Ficoll-Hypaque gradient as previously described (15).
PMN preparations were 97% pure. Final cell suspensions
were adjusted to 5 x 106 PMN per ml in Hanks balanced salt
solution. The PMN were 95% viable by trypan blue exclu-
sion.
Tissue culture cells. HEp-2 and McCoy cells (Flow Labo-
ratories, Irvine, United Kingdom) were grown in minimal
essential medium (Flow) supplemented with 1 mM HEPES
(N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid; Flow)
and containing 10% fetal calf serum (Flow) without antibiot-
ics. For each experiment, cells were detached from tissue
* Corresponding author.
culture bottles with trypsin-EDTA (Flow), washed once with
minimal essential medium containing fetal calf serum (10%),
and suspended in Hanks balanced salt solution at a concen-
tration of 5 x 106 cells per ml.
Sparfloxacin uptake by phagocytes. Uptake of radiolabeled
sparfloxacin by phagocytes was determined by means of a
velocity gradient centrifugation technique described by
Klempner and Styrt (6). ['4C]sparfloxacin (21.4 ,Ci/mg) and
sparfloxacin were kindly supplied by Rhone-Poulenc (Paris,
France). In these experiments, PMN or tissue cells were
incubated in Hanks balanced salt solution containing differ-
ent concentrations of sparfloxacin (0.5, 1, 2, 5, 10, and 25
mg/liter). After different incubation periods at 37°C, cells
were separated from extracellular solution by centrifugation
through a water-impermeable silicone oil barrier in a micro-
centrifuge tube. A 10-,ul aliquot of the extracellular medium
and the entire cell pellet, obtained by cutting off the portion
of the microfuge tube containing the pellet, were placed in 3
ml of scintillation fluid (Ready Micro, Beckman Instruments,
Inc., Fullerton, Calif.) and counted in a liquid scintillation
counter (model LS 1801; Beckman). After determination of
the cell volume with radiolabeled polyethylene glycol and
water (New England Nuclear), the accumulation rate of the
antimicrobial agent in PMN or tissue cells (cellular to
extracellular concentration [C/E] ratio) was calculated as
described previously (6).
Characterization of sparfloxacin uptake. Further studies to
elucidate the mechanism of sparfloxacin uptake by PMN
were performed as described previously (4). The importance
of cell viability was studied by using PMN killed by exposure
to 10% Formalin for 30 min. These cells were then washed
and suspended in fresh medium. Moreover, the influences of
environmental temperature, pH, metabolic inhibitors, and
potential competitive inhibitors were evaluated. The influ-
ence of temperature was examined by comparing antimicro-
bial uptake at 4 and 37°C. The pH profiles of sparfloxacin
uptake in media preadjusted to different external pHs (pHs
6, 7, and 8) by the addition of 10 N HCI or 10 N NaOH were
measured. Sodium fluoride (Sigma Chemical Co., St. Louis,
Mo.) and sodium cyanide (Sigma) were used as metabolic
inhibitors at 10-3 and 5 x 10' M. The PMN in Hanks
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balanced salt solution with or without metabolic inhibitors
were incubated for 30 min at 37°C. Sparfloxacin at a final
concentration of 2 ,ug/ml was then added, and the uptake was
measured as described above. Other substances were eval-
uated for possible competitive inhibition of sparfloxacin
uptake. These materials included a nucleoside (adenosine
[Sigma]), D-glucose (Sigma), and an L-amino acid (lysine
monohydrochloride [E. Merck AG, Darmstadt, Germany]).
These substances were added to the cells at the same time as
sparfloxacin. The uptake of sparfloxacin was measured as
described above. Cell viability was always measured after
each experiment by trypan blue exclusion and was always
higher than 95%.
The efflux, or reversibility of binding, of PMN-associated
sparfloxacin was also studied. The PMN were incubated for
20 min at 37°C with sparfloxacin, collected by centrifugation,
and rapidly suspended in sparfloxacin-free medium. PMN-
associated sparfloxacin was quantified at various intervals
(5, 10, and 20 min) after removal of the extracellular spar-
floxacin.
In a series of experiments, sparfloxacin (extracellular
concentration, 2 mg/liter) uptake by human PMN was mea-
sured after stimulation of the cells with 200 nM phorbol
myristate acetate (Sigma), opsonized zymosan (0.9 mg/liter;
Sigma), and S. aureus ATCC 25923 opsonized in 5% pooled
human serum (15 min, 37°C) at a 10/1 ratio of bacteria to
PMN. Phorbol myristate acetate, zymosan, or opsonized
bacteria were added to the PMN suspensions at the same
time as the antimicrobial agents, and the uptake was mea-
sured as described above.
Partition coefficients of quinolones. The partition coeffi-
cients of quinolones were determined by the modified
method of Nikaido (10). Solutions (10 mg/liter) of quinolones
were made in 0.1 M phosphate buffer (pH 7.2). After being
shaken with an equal volume ofp-xylene at 25°C for 48 h and
centrifuged at 1,870 x g for phase separation, the concen-
trations of quinolones in the aqueous phase were determined
by a spectrophotometric assay measuring the A292 for spar-
floxacin and the A294 for ofloxacin (Hoechst). The partition
coefficients were expressed as the ratio of the amount of the
compound in the p-xylene to that in the aqueous phase.
Intracellular activities of antimicrobial agents. To evaluate
the intracellular activities of antimicrobial agents, a previ-
ously described method was used (14). Briefly, 0.1 ml of
opsonized bacterial suspension (5 x 10 CFU/ml) and 0.1 ml
of PMN (5 x 106 PMN per ml) were combined in a series of
polypropylene biovials (Beckman) and incubated in a shaker
(250 rpm) for 60 min at 37°C. After incubation, extracellular
bacteria were removed by differential centrifugation. Cells
were then suspended in 0.2 ml of RPMI medium (GIBCO,
United Kingdom). At this time, different concentrations of
sparfloxacin were added, and the vials were incubated in a
shaker (250 rpm) at 37°C. Vials were removed at time zero
and after 3 h of incubation (control and samples with
antimicrobial agents). Cells were lysed in distilled water, and
samples were diluted and pour plated in agar. Colonies were
counted after 24 h of incubation at 37°C. The data were
expressed as percentages of staphylococci surviving com-
pared with levels in controls (without antimicrobial agents)
at 3 h. In addition to determining bacterial survival, morpho-
logic studies were also routinely performed at time zero and
after 3 h of incubation to evaluate the disposition of bacteria
(cell associated or extracellular). Samples (50 ,ul) were
removed from biovials and deposited on glass slides. After
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FIG. 1. Sparfloxacin uptake by human PMN (Z) and two tissue
culture epithelial cell lines (HEp-2 [K] and McCoy [-]) (n = 7). The
extracellular concentration was 2 mg/liter.
light microscopy. All assays were performed in duplicate
with PMN from five different donors.
Statistical analysis of data. Data were expressed as the
means + standard deviations. Differences among groups
were compared by analysis of variance, which was used to
assess statistical significance at P c 0.05.
RESULTS
Uptake of sparfloxacin by PMN and tissue culture cells.
Figure 1 shows the kinetics of the uptake of sparfloxacin by
PMN and two tissue culture epithelial cell lines. Sparfloxacin
uptake by these cells was rapid and high. With extracellular
concentrations of 2 mg/liter, the C/E ratios were higher than
4 after only 1 min of incubation for all types of cells.
The effect of the extracellular concentration of sparfloxa-
cin on its uptake by human PMN is shown in Fig. 2.
Cell-associated sparfloxacin was not saturable at extracellu-
lar concentrations ranging from 0.5 to 25 mg/liter.
The effects of environmental temperature, pH, cell viabil-
ity, and metabolic inhibitors on the intracellular penetration
of sparfloxacin are described in Table 1. The uptake of
sparfloxacin was not different when viable PMN at 4°C or
Formalin-killed cells at 37°C were used. Sparfloxacin uptake
by PMN was slightly higher at pH 6 and significantly
decreased (P < 0.05) at pH 8. Neither sodium fluoride nor
sodium cyanide affected the intracellular penetration of this
agent.
Potential competitive substrates described for other anti-
microbial agents (adenosine, glucose, and L-amino acids)
were evaluated. The presence of adenosine significantly
impaired the rate of uptake of sparfloxacin by human PMN
(C/E ratio, 4.7 + 1.4; P < 0.05 compared with controls [6.7
+ 1.3]). The C/E ratios for glucose and L-lysine were 7.4 +
1.9 and 8.0 + 2.0, respectively.
The stimulation of PMN by a membrane activator (phor-
bol myristate acetate) and the phagocytosis of opsonized S.
aureus did not affect the intracellular penetration of spar-
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FIG. 2. Sparfloxacin uptake by human PMN at different extra-
cellular concentrations (n = 9). Incubations were for 20 min.
floxacin (C/E ratios of 5.9 + 1.3 and 6.0 2.1, respectively).
The phagocytosis of opsonized zymosan, however, signifi-
cantly increased the uptake of sparfloxacin by PMN (C/E
ratio of 12.3 + 2.8; P < 0.05).
To evaluate whether sparfloxacin that had been taken up
by PMN was tightly bound to cellular components, we
studied the kinetics of efflux (Fig. 3). The reversibility of
binding of sparfloxacin was rapid, with 60% of the cell-
associated drug being lost by 5 min (compare values at 20
and 25 min in Fig. 3).
Partition coefficients of quinolones. The partition coeffi-
cients of sparfloxacin and ofloxacin were 0.250 and 0.090,
respectively. This means that sparfloxacin is approximately
four more times hydrophobic than ofloxacin.
Intracellular activity of sparfloxacin. The intracellular ac-
tivities of different concentrations of sparfloxacin against S.
aureus are shown in Fig. 4. At extracellular concentrations
TABLE 1. Effects of cell viability, environmental temperature,
pH, and metabolic inhibitors on the intracellular penetration
of sparfloxacin in human PMN (n = 5)
Conditiona C/E ratio
Viable cells, 37°C........... 6.5 +1.2
Viable cells, 4°C............ 5.3 +1.3
Dead cells, 37°C........... 6.1 +1.5
pH 6............ 7.9 ± 2.4
pH 7............ 6.4 ± 1.1
pH 8........... 3.9 ±1.lb
NaF............ 6.6 +2.8
NaCN........... 6.2 ± 1.4
a Experiments were carried out for 20 min at an extracellular concentration
of 2 mg/liter.
b p < 0.05 compared with the control.
FIG. 3. Efflux of intracellular sparfloxacin from human PMN
after removal of extracellular drug (n = 3). Cells were centrifuged
and suspended in drug-free medium after 10 min of sparfloxacin
accumulation.
of 0.5 and 1 mg/liter, sparfloxacin produced a significant
reduction in the survival rate of S. aureus in PMN.
DISCUSSION
In this study, the uptake of radiolabeled sparfloxacin by
human PMN and tissue culture cells has been evaluated.
Using radiolabeled sparfloxacin, we have observed that this
agent is highly concentrated in both types of cells even at
therapeutical concentrations. The C/E ratios of sparfloxacin
for PMN were similar to those observed for ciprofloxacin,
ofloxacin, and other quinolones by means of a fluorometric
assay (11). The intracellular penetration of sparfloxacin into
tissue epithelial cells and fibroblasts was, however, signifi-
cantly higher than that observed for ofloxacin (12). This
could be related to the fact that sparfloxacin is more hydro-
phobic than ofloxacin and theoretically could pass more
easily through the cell membrane.
We have previously described a sensitive fluorometric
assay, which avoids the use of radiolabeled antimicrobial
agents, to measure intracellular concentrations of quinolo-
nes (11, 12). Nevertheless, although sparfloxacin contains
two fluor substituents in its molecule, it did not emit any
fluorescence under several experimental conditions.
The uptake of sparfloxacin by PMN was rapid, nonsatura-
ble (at extracellular concentrations between 1 and 25 mg/
liter), reversible, and not energy dependent. It was slightly
increased at acidic pH but significantly reduced at pH 8. This
phenomenon could be related to the fact that all the quino-
lones display a free carboxyl group which at pH 8 should be
in its unprotonated form (-COO-). It has been observed
that the ionized forms of weak organic acids and bases
















































































microbial agents (5). In our study, sparfloxacin showed good
intracellular activity against S. aureus in PMN. These results
were similar to those described for other quinolones (13).
In summary, sparfloxacin penetrates into human PMN and
tissue culture cells, reaching intracellular concentrations
several times higher than extracellular concentrations
mainly by a passive mechanism while remaining active
intracellularly. The high antimicrobial activity of this com-
pound added to the properties observed in this study en-





FIG. 4. Effect of sparfloxacin on survival of S. aureus ATCC
25923 in human PMN (n = 5). Data are expressed as percentages of
levels in control (without antimicrobial agent). The MIC and MBC
for this strain were 0.125 and 0.25 mg/liter, respectively. *, P < 0.05.
than their un-ionized forms (16). The intracellular penetra-
tion of sparfloxacin in human PMN was not affected by
environmental temperature and cell viability. All these data
point out that the uptake of sparfloxacin by PMN occurs by
a passive mechanism. Similar results were described by
Carlier et al. for murine macrophages (1).
The influences of phagocytosis and cell membrane stimuli
on the uptake of sparfloxacin were of interest. An unex-
pected finding for which we do not have a clear explanation
yet was that ingestion of opsonized S. aureus did not affect
the intracellular penetration of sparfloxacin, but the inges-
tion of opsonized zymosan significantly increased the C/E
ratios of sparfloxacin. Nevertheless, the uptake of both
antimicrobial agents was still high in both conditions.
Another interesting finding is the effect of adenosine on
the intracellular penetration of sparfloxacin. There are some
antimicrobial agents such as clindamycin which are trans-
ported into human PMN via the nucleoside transport system
(12). This mechanism, however, is active and requires en-
ergy. The mechanism whereby sparfloxacin accumulates in
cells is not yet known, and no simple model can be presented
in view of the findings presented above. Although most data
point toward a passive mechanism, some are typical of an
active mechanism. More than one simple mechanism may be
involved. In fact, not all the quinolones show the same
mechanism for intracellular penetration. Our previous data
pointed to an active mechanism for ofloxacin (11). More-
over, sparfloxacin is much more hydrophobic than ofloxacin,
a characteristic that theoretically allows easier penetration
through cell membranes. Nevertheless, further studies are
being performed to elucidate this point.
A contrast between phagocyte antimicrobial agent uptake
and intracellular activity has been described for a few anti-
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